This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Berinert (Subcutaneous)

CSL Limited

Drug Names(s): CE1145, C1-INH concentrate, human C1-esterase inhibitor concentrate, CSL830, CSL 830

Description: BioMedTracker has separate drug profiles for the intravenous and subcutaneous formulations of Berinert. Please also see Berinert (Intravenous).

C1-INH inhibitor concentrate is a pasteurized concentrate of human-derived C1 esterase inhibitor.

Berinert (Subcutaneous) News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug